{"id":"NCT00962780","sponsor":"Pfizer","briefTitle":"Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine","officialTitle":"A Phase 3, Open-label, Single-Arm Trial to Evaluate the Safety, Tolerability and Immunogenicity of 2 and 3 Doses of 13vPnC in HIV-Infected Subjects 6 Years of Age and Older Who Have Not Been Previously Immunized With Pneumococcal Vaccine","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-03","primaryCompletion":"2013-04","completion":"2013-04","firstPosted":"2009-08-20","resultsPosted":"2014-11-17","lastUpdate":"2014-11-17"},"enrollment":303,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["HIV Infections","Pneumococcal Infections"],"interventions":[{"type":"BIOLOGICAL","name":"13-valent Pneumococcal Conjugate Vaccine (13vPnC)","otherNames":[]},{"type":"BIOLOGICAL","name":"23-valent Pneumococcal Polysaccharide Vaccine (23vPS)","otherNames":[]},{"type":"PROCEDURE","name":"Blood draw","otherNames":[]},{"type":"PROCEDURE","name":"Blood draw","otherNames":["Screening blood draw(s)"]}],"arms":[{"label":"1","type":"EXPERIMENTAL"}],"summary":"The study will evaluate the safety, tolerability and immunogenicity of a 13-valent pneumococcal conjugate vaccine (13vPnC) in HIV-infected subjects 6 years of age or older who have not been previously immunized with a pneumococcal vaccine. All subjects will receive 3 doses of 13vPnC and 1 dose of 23-valent pneumococcal polysaccharide vaccine (23vPS), with each dose given approximately 1 month apart.","primaryOutcome":{"measure":"Geometric Mean Fold Rise (GMFR) for Serotype-Specific Pneumococcal Immunoglobulin G (IgG) Antibody From 1 Month After 13vPnC Dose 2 to 1 Month After 13vPnC Dose 3 in All Participants","timeFrame":"1 month after 13vPnC Dose 2, 1 month after 13vPnC Dose 3","effectByArm":[{"arm":"13vPnC, 23vPS (All Participants)","deltaMin":1.03,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":11,"countries":["Romania","South Africa"]},"refs":{"pmids":["25888646"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=6115A1-3002&StudyName=Safety%20and%20Immunogenicity%20of%2013-Valent%20pneumococcal%20conjugate%20vaccine%20%2813vPnC%29%20in%20HIV-Infected%20Subjects%206%20Years%20of%20Age%20or%20Older%20who"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":301},"commonTop":["Pain at injection site (Any)","Pain at injection site (Mild)","Muscle pain (Any)","Fatigue (Any)","Headache (Any)"]}}